These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 21659570)

  • 41. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
    Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
    PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sorting out Toll signals.
    Fitzgerald KA; Chen ZJ
    Cell; 2006 Jun; 125(5):834-6. PubMed ID: 16751092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
    Toshchakov VU; Basu S; Fenton MJ; Vogel SN
    J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbial recognition by Toll-like receptors.
    Takeda K; Akira S
    J Dermatol Sci; 2004 Apr; 34(2):73-82. PubMed ID: 15033189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.
    Takeshita F; Tanaka T; Matsuda T; Tozuka M; Kobiyama K; Saha S; Matsui K; Ishii KJ; Coban C; Akira S; Ishii N; Suzuki K; Klinman DM; Okuda K; Sasaki S
    J Virol; 2006 Jul; 80(13):6218-24. PubMed ID: 16775309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
    Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
    J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
    O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
    J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
    George J; Kubarenko AV; Rautanen A; Mills TC; Colak E; Kempf T; Hill AV; Nieters A; Weber AN
    J Immunol; 2010 Mar; 184(6):3025-32. PubMed ID: 20164415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Uematsu S; Hoshino K; Kaisho T; Takeuchi O; Takeda K; Akira S
    Nat Immunol; 2003 Nov; 4(11):1144-50. PubMed ID: 14556004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular cloning and expression analysis of chicken MyD88 and TRIF genes.
    Wheaton S; Lambourne MD; Sarson AJ; Brisbin JT; Mayameei A; Sharif S
    DNA Seq; 2007 Dec; 18(6):480-6. PubMed ID: 17676477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unique features of chicken Toll-like receptors.
    Keestra AM; de Zoete MR; Bouwman LI; Vaezirad MM; van Putten JP
    Dev Comp Immunol; 2013 Nov; 41(3):316-23. PubMed ID: 23628643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
    Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
    J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterologous Expression and Assembly of Human TLR Signaling Components in
    Coronas-Serna JM; Del Val E; Kagan JC; Molina M; Cid VJ
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.